GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » 3-Year Revenue Growth Rate

Vivoryon Therapeutics NV (FRA:05Y) 3-Year Revenue Growth Rate : 0.00% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV 3-Year Revenue Growth Rate?

Vivoryon Therapeutics NV's Revenue per Share for the six months ended in Dec. 2023 was €-0.14.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Vivoryon Therapeutics NV's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Vivoryon Therapeutics NV's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivoryon Therapeutics NV's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivoryon Therapeutics NV's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Vivoryon Therapeutics NV's 3-Year Revenue Growth Rate falls into.



Vivoryon Therapeutics NV 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Vivoryon Therapeutics NV  (FRA:05Y) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Vivoryon Therapeutics NV 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Vivoryon Therapeutics NV's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivoryon Therapeutics NV (FRA:05Y) Business Description

Traded in Other Exchanges
Address
Weinbergweg 22, Halle, SN, DEU, 06120
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV (FRA:05Y) Headlines

No Headlines